Chemokines: key players in cancer progression and metastasis.
about
MicroRNAs: Novel immunotherapeutic targets in colorectal carcinomaCXCR3 in carcinoma progressionMolecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tractOverexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma.Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge.Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer.CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signalingGlobal gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients.Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma.MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoAExpression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy.CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells.CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer.
P2860
Q26747339-5B60C554-69D6-4BA1-AD8F-EC72699D60B9Q26826928-CE6DE6BA-90D2-4693-96AD-8EE0D8140FB7Q27013620-2E97D104-C183-48C7-B78F-51C150B24735Q34304058-E16323B2-4382-4CFD-83C1-EE7D71FB7BA2Q34428538-C5CEF719-A9C2-4F7A-9E22-2D610E1DAB25Q34692268-48132590-CE88-4F75-8736-E00CE11D2B45Q35078196-B3EE8CB9-48E7-4776-97E8-7C08A6354392Q35884951-37DA3D97-BD31-48AF-8267-4516AF7B9DE4Q36159383-4BC14ACD-AAF5-4E7C-AD03-D4A55C47DEDFQ36225000-713ED47E-DE12-4EE6-A437-C9AC691F3396Q36960019-2434F7F0-0854-47D0-94D9-2E0F990D84EBQ38645374-34E784DB-EFC1-40B7-8515-A8CF4D026AC2Q38986557-3A45A0F7-AC23-493C-B9FF-EBB65A60B984Q40449073-8BBEDB87-1B24-4A0F-8120-8CB878BBFCFDQ48527882-0770AEFC-A79E-48EE-A752-0CB0496649CAQ52728031-379CAA98-DACF-4A4B-AD3C-F94B89F2C1E6
P2860
Chemokines: key players in cancer progression and metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemokines: key players in cancer progression and metastasis.
@en
Chemokines: key players in cancer progression and metastasis.
@nl
type
label
Chemokines: key players in cancer progression and metastasis.
@en
Chemokines: key players in cancer progression and metastasis.
@nl
prefLabel
Chemokines: key players in cancer progression and metastasis.
@en
Chemokines: key players in cancer progression and metastasis.
@nl
P2093
P2860
P356
P1476
Chemokines: key players in cancer progression and metastasis.
@en
P2093
James W Lillard
Rajesh Singh
Shailesh Singh
P2860
P304
P356
10.2741/246
P577
2011-06-01T00:00:00Z